Format

Send to

Choose Destination
Crit Rev Clin Lab Sci. 2006;43(2):183-202.

Function of PPARgamma and its ligands in lung cancer.

Author information

1
Department of Surgery, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.

Abstract

Peroxisome proliferator-activated receptors gamma (PPAR?) is a transcriptional factor belonging to the ligand-activated nuclear receptor superfamily. PPAR? is highly expressed in adipose tissue and has a dominant regulatory role in adipocyte differentiation. In humans, PPAR? is expressed in multiple tissues such as the breast, colon, lung, ovary, and placenta. In addition to adipogenic and anti-inflammatory effects, PPAR? activation has been shown to be anti-proliferative by virtue of its differentiation-promoting effect, suggesting that activation of PPAR? may be useful in slowing or arresting the proliferation of de-differentiated tumor cells. A number of PPAR? ligands, such as natural prostaglandins and synthetic anti-diabetic thiazolidinediones (TZDs), have been identified. The discovery of PPAR? agonists has enabled the elucidation of the mechanisms involved in the multiple effects of PPAR? on the inhibition of tumor cell growth. The importance of this transcription factor in physiology and pathophysiology has stimulated much research in this field. This review describes structural features of PPAR?, mechanisms of PPAR? gene transcription, and recent developments in the discovery of its biological functions on growth inhibition of lung tumors. Prospects for future research leading to new therapies for lung cancer are also discussed.

PMID:
16517422
DOI:
10.1080/10408360600552587
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center